168 related articles for article (PubMed ID: 6440451)
1. Conjugation of antibodies with bifunctional chelating agents: isothiocyanate and bromoacetamide reagents, methods of analysis, and subsequent addition of metal ions.
Meares CF; McCall MJ; Reardan DT; Goodwin DA; Diamanti CI; McTigue M
Anal Biochem; 1984 Oct; 142(1):68-78. PubMed ID: 6440451
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of novel bifunctional chelators and their use in preparing monoclonal antibody conjugates for tumor targeting.
Westerberg DA; Carney PL; Rogers PE; Kline SJ; Johnson DK
J Med Chem; 1989 Jan; 32(1):236-43. PubMed ID: 2491892
[TBL] [Abstract][Full Text] [Related]
3. Introduction of five potentially metabolizable linking groups between 111In-cyclohexyl EDTA derivatives and F(ab')2 fragments of anti-carcinoembryonic antigen antibody--I. A new reproducible synthetic method.
Gestin JF; Faivre-Chauvet A; Mease RC; Sai-Maurel C; Thédrez P; Slinkin M; Meinken GE; Srivastava SC; Chatal JF
Nucl Med Biol; 1993 Aug; 20(6):755-62. PubMed ID: 8401376
[TBL] [Abstract][Full Text] [Related]
4. Bis(hydroxamamide)-based bifunctional chelating agent for 99mTc labeling of polypeptides.
Xu LC; Nakayama M; Harada K; Kuniyasu A; Nakayama H; Tomiguchi S; Kojima A; Takahashi M; Ono M; Arano Y; Saji H; Yao Z; Sakahara H; Konishi J; Imagawa Y
Bioconjug Chem; 1999; 10(1):9-17. PubMed ID: 9893958
[TBL] [Abstract][Full Text] [Related]
5. Simplified method for conjugating macrocyclic bifunctional chelating agents to antibodies via 2-iminothiolane.
McCall MJ; Diril H; Meares CF
Bioconjug Chem; 1990; 1(3):222-6. PubMed ID: 2096914
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of a new bifunctional chelating agent for the preparation of radioimmunoconjugates.
Somayaji VV; Guay V; Peng Z; Sykes TR; Noujaim AA
Q J Nucl Med; 1995 Dec; 39(4):300-10. PubMed ID: 8624793
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of N-[tris[2-[[N-(benzyloxy)amino]carbonyl]ethyl]methyl]succinamic acid, trisuccin. Hydroxamic acid derivatives as a new class of bifunctional chelating agents.
Safavy A; Buchsbaum DJ; Khazaeli MB
Bioconjug Chem; 1993; 4(3):194-8. PubMed ID: 8324008
[TBL] [Abstract][Full Text] [Related]
8. Carboxymethyl-substituted bifunctional chelators: preparation of aryl isothiocyanate derivatives of 3-(carboxymethyl)-3-azapentanedioic acid, 3,12-bis(carboxymethyl)-6,9-dioxa-3,12-diazatetradecanedioic++ + acid, and 1,4,7,10-tetraazacyclododecane-N,N',N",N'''-tetraacetic acid for use as protein labels.
Kline SJ; Betebenner DA; Johnson DK
Bioconjug Chem; 1991; 2(1):26-31. PubMed ID: 1908704
[TBL] [Abstract][Full Text] [Related]
9. Maleimidocysteineamido-DOTA derivatives: new reagents for radiometal chelate conjugation to antibody sulfhydryl groups undergo pH-dependent cleavage reactions.
Lewis MR; Shively JE
Bioconjug Chem; 1998; 9(1):72-86. PubMed ID: 9460549
[TBL] [Abstract][Full Text] [Related]
10. Chelating agents for the binding of metal ions to macromolecules.
Sundberg MW; Meares CF; Goodwin DA; Diamanti CI
Nature; 1974 Aug; 250(467):587-8. PubMed ID: 4210879
[No Abstract] [Full Text] [Related]
11. A convenient and flexible approach for introducing linkers on bifunctional chelating agents.
Studer M; Meares CF
Bioconjug Chem; 1992; 3(5):420-3. PubMed ID: 1420441
[TBL] [Abstract][Full Text] [Related]
12. Nature of the bifunctional chelating agent used for radioimmunotherapy with yttrium-90 monoclonal antibodies: critical factors in determining in vivo survival and organ toxicity.
Kozak RW; Raubitschek A; Mirzadeh S; Brechbiel MW; Junghans RP; Gansow OA; Waldmann TA
Cancer Res; 1989 May; 49(10):2639-44. PubMed ID: 2785435
[TBL] [Abstract][Full Text] [Related]
13. N,N'-bis(2-hydroxybenzyl)-1-(4-bromoacetamidobenzyl)-1,2 -ethylenediamine-N,N'-diacetic acid: a new bifunctional chelate for radiolabeling antibodies.
Mathias CJ; Sun YZ; Welch MJ; Connett JM; Philpott GW; Martell AE
Bioconjug Chem; 1990; 1(3):204-11. PubMed ID: 2129013
[TBL] [Abstract][Full Text] [Related]
14. Chelate conjugates of monoclonal antibodies for imaging lymphoid structures in the mouse.
Goodwin DA; Meares CF; McCall MJ; Haseman MK; McTigue M; Diamanti CI; Chaovapong W
J Nucl Med; 1985 May; 26(5):493-502. PubMed ID: 3921673
[TBL] [Abstract][Full Text] [Related]
15. The synthesis and use of activated N-benzyl derivatives of diethylenetriaminetetraacetic acids: alternative reagents for labeling of antibodies with metal ions.
Mukkala VM; Mikola H; Hemmilä I
Anal Biochem; 1989 Feb; 176(2):319-25. PubMed ID: 2500868
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the stability and animal biodistribution of gadolinium (III) benzylamine-derivatized diethylenetriaminepentaacetic acid.
Deal KA; Motekaitis RJ; Martell AE; Welch MJ
J Med Chem; 1996 Aug; 39(16):3096-3106. PubMed ID: 8759630
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of affinity-label chelates: a novel synthetic method of coupling ethylenediaminetetraacetic acid to amine functional groups.
Haner M; Eidson AF; Darnall DW; Birnbaum ER
Arch Biochem Biophys; 1984 Jun; 231(2):477-86. PubMed ID: 6428318
[TBL] [Abstract][Full Text] [Related]
18. Characterization of antibody-chelator conjugates: determination of chelator content by terbium fluorescence titration.
Brandt KD; Schnobrich KE; Johnson DK
Bioconjug Chem; 1991; 2(1):67-70. PubMed ID: 1908706
[TBL] [Abstract][Full Text] [Related]
19. Bis(3-hydroxy-4-pyridinone)-EDTA derivative as a potential therapeutic Al-chelating agent. Synthesis, solution studies and biological assays.
Santos MA; Gama S; Gano L; Farkas E
J Inorg Biochem; 2005 Sep; 99(9):1845-52. PubMed ID: 16099511
[TBL] [Abstract][Full Text] [Related]
20. Macrocyclic chelates of radiometals for diagnosis and therapy.
Meares CF; Moi MK; Diril H; Kukis DL; McCall MJ; Deshpande SV; DeNardo SJ; Snook D; Epenetos AA
Br J Cancer Suppl; 1990 Jul; 10():21-6. PubMed ID: 2383477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
